Cover Image

The Molecular Mechanisms Study of Engeletin Suppresses RANKL-Induced Osteoclastogenesis and Inhibits Ovariectomized Murine Model Bone Loss

Mingzhe Feng,1,&ast; Lin Liu,2,&ast; Jiang Wang,1 Jialang Zhang,1 Zechao Qu,1 Yanjun Wang,3 Baorong He1 1Department of Spine Surgery, Honghui Hospital, School of Medicine, Xi'an Jiao Tong University, Xi'an, People's Republic of China; 2Department of Critical Care Medicine, Hon...

Full description

Saved in:

Bibliographic Details
Main Authors:	Feng M (Author), Liu L (Author), Wang J (Author), Zhang J (Author), Qu Z (Author), Wang Y (Author), He B (Author)
Format:	Book
Published:	Dove Medical Press, 2023-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tetrandrine Prevents Bone Loss in Ovariectomized Mice by Inhibiting RANKL-Induced Osteoclastogenesis
by: Zeyuan Zhong, et al.
Published: (2020)

Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis
by: Chang-hong Li, et al.
Published: (2021)

Corrigendum: Nitazoxanide, an antiprotozoal drug, reduces bone loss in ovariectomized mice by inhibition of RANKL-induced osteoclastogenesis
by: Chang-hong Li, et al.
Published: (2023)

Betulinic Acid Protects From Bone Loss in Ovariectomized Mice and Suppresses RANKL-Associated Osteoclastogenesis by Inhibiting the MAPK and NFATc1 Pathways
by: Jiyong Wei, et al.
Published: (2020)

BCI Suppresses RANKL-Mediated Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss
by: Chenhui Cai, et al.
Published: (2021)

Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways
by: Xue Yang, et al.
Published: (2021)

Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo
by: Peng J, et al.
Published: (2020)

Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss
by: Dahu Qi, et al.
Published: (2021)

Vindoline Inhibits RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss in Mice
by: Yunfei Zhan, et al.
Published: (2020)

Water extract of Cnidii Rhizoma suppresses RANKL-induced osteoclastogenesis in RAW 264.7 cell by inhibiting NFATc1/c-Fos signaling and prevents ovariectomized bone loss in SD-rat
by: Ka-Yeon Lee, et al.
Published: (2019)

ED-71 Improves Bone Mass in Ovariectomized Rats by Inhibiting Osteoclastogenesis Through EphrinB2-EphB4-RANKL/OPG Axis
by: Wang K, et al.
Published: (2024)

Berbamine inhibits RANKL- and M-CSF-mediated osteoclastogenesis and alleviates ovariectomy-induced bone loss
by: Guobin Qi, et al.
Published: (2022)

Theaflavin-3, 3'-Digallate Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Ovariectomy-Induced Bone Loss in Mice
by: Zexin Ai, et al.
Published: (2020)

Oleanolic acid exerts bone protective effects in ovariectomized mice by inhibiting osteoclastogenesis
by: Dongfeng Zhao, et al.
Published: (2018)

Dencichine prevents ovariectomy-induced bone loss and inhibits osteoclastogenesis by inhibiting RANKL-associated NF-κB and MAPK signaling pathways
by: Dingwei Cang, et al.
Published: (2021)

Nardosinone Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Lipopolysaccharide-Induced Alveolar Bone Resorption
by: Chenguang Niu, et al.
Published: (2017)

Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and -independent autophagic responses
by: Guoyou Zhang, et al.
Published: (2019)

Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
by: Jiarui Li, et al.
Published: (2022)

Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
by: Jun-ming Huang, et al.
Published: (2018)

The systemic bone protective effects of Gushukang granules in ovariectomized mice by inhibiting osteoclastogenesis and stimulating osteoblastogenesis
by: Qiang Wang, et al.
Published: (2018)

Juglanin Inhibits Osteoclastogenesis in Ovariectomized Mice via the Suppression of NF-κB Signaling Pathways
by: Fangxue Zhang, et al.
Published: (2021)

Corrigendum: Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
by: Jun-ming Huang, et al.
Published: (2018)

12-Deoxyphorbol-13-Hexadecanoate Abrogates OVX-Induced Bone Loss in Mice and Osteoclastogenesis via Inhibiting ROS Level and Regulating RANKL-Mediated NFATc1 Activation
by: Qi He, et al.
Published: (2022)

Unveiling the potential of Butylphthalide: inhibiting osteoclastogenesis and preventing bone loss
by: Feng Yanbin, et al.
Published: (2024)

Bushen huoxue decoction inhibits RANKL-stimulated osteoclastogenesis and glucocorticoid-induced bone loss by modulating the NF-κB, ERK, and JNK signaling pathways
by: Yamei Liu, et al.
Published: (2022)

Anemonin Attenuates RANKL-Induced Osteoclastogenesis and Ameliorates LPS-Induced Inflammatory Bone Loss in Mice via Modulation of NFATc1
by: Huanhuan Hou, et al.
Published: (2020)

Corrigendum: Bushen huoxue decoction inhibits RANKL-stimulated osteoclastogenesis and glucocorticoid-induced bone loss by modulating the NF-κB, ERK, and JNK signaling pathways
by: Yamei Liu, et al.
Published: (2023)

Hesperetin Prevents Bone Resorption by Inhibiting RANKL-Induced Osteoclastogenesis and Jnk Mediated Irf-3/c-Jun Activation
by: Qiang Zhang, et al.
Published: (2018)

Cycloastragenol Attenuates Osteoclastogenesis and Bone Loss by Targeting RANKL-Induced Nrf2/Keap1/ARE, NF-κB, Calcium, and NFATc1 Pathways
by: Gang Wang, et al.
Published: (2022)

Artocarpus tonkinensis Extract Inhibits LPS-Triggered Inflammation Markers and Suppresses RANKL-Induced Osteoclastogenesis in RAW264.7
by: Elena Orecchini, et al.
Published: (2021)

Schisandrin B Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss
by: Jia Wang, et al.
Published: (2020)

Dihydromyricetin Protects against Bone Loss in Ovariectomized Mice by Suppressing Osteoclast Activity
by: Libo Zhao, et al.
Published: (2017)

Eudebeiolide B Inhibits Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Regulating RANKL-Induced NF-κB, c-Fos and Calcium Signaling
by: Mi-Hwa Kim, et al.
Published: (2020)

Inhibitory Effect of Chlorpromazine on RANKL-Induced Osteoclastogenesis in Mouse Bone Marrow Cells
by: Hiroharu Kawamura, et al.
Published: (2011)

Baohuoside I Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss
by: Min Ma, et al.
Published: (2022)

Celastrol Attenuates RANKL-Induced Osteoclastogenesis in vitro and Reduces Titanium Particle-Induced Osteolysis and Ovariectomy-Induced Bone Loss in vivo
by: Qiang Xu, et al.
Published: (2021)

Administration of SB239063 Ameliorates Ovariectomy-Induced Bone Loss via Suppressing Osteoclastogenesis in Mice
by: Bao Huang, et al.
Published: (2019)

Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression
by: Wei Lin, et al.
Published: (2021)

Deacylcynaropicrin Inhibits RANKL-Induced Osteoclastogenesis by Inhibiting NF-κB and MAPK and Promoting M2 Polarization of Macrophages
by: Zhikun Li, et al.
Published: (2019)

Effect of enhanced masticatory force on OPG, RANKL and MGF in alveolar bone of ovariectomized rats
by: Zongmin Ma, et al.
Published: (2020)